Equity Overview
Price & Market Data
Price: $15.22
Daily Change: -$1.50 / 9.86%
Daily Range: $15.22 - $17.57
Market Cap: $899,430,080
Daily Volume: 371,732
Performance Metrics
1 Week: 3.46%
1 Month: 35.38%
3 Months: 84.62%
6 Months: 75.61%
1 Year: -23.72%
YTD: -3.65%
Company Details
Employees: 52
Sector: Health technology
Industry: Biotechnology
Country:
Details
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.